Bibliography for Item 2 in BGP

Unreferenced links

• http://www.nyba.org/
  • New York Biotechnology Association

• http://www.thinkbiotech.com/
  • Think Biotech

• http://trial.selectory.com/google/mtw_biotechnology_company.html?registrationcode=goog0841&RepCode=MTW&LeadDest=DNB
  • Biotech company database

• http://www.biotech-u.com/courses/?

• http://www.dmoz.org/Business/Biotechnology_and_Pharmaceuticals/
  • Directory of Biotech links

• http://www.palgrave-journals.com/jcb/index.html
  • Journal of Commercial Biotechnology

• http://www.biocentury.com/BCApp/BioCenturyCommon/BCAbout.aspx?ss=2
  • Biocentury. Provides corporate reports

• http://www.nature.com/bioent/index.html
  • Bioentrepreneur

• http://www.drugpatentwatch.com/innovation/
  • Drug patent expiration dates

• http://www.nature.com/nrd/journal/v5/n4/abs/nrd2019.html
  • Nature Reviews on Drug Discoveries

• http://www.nature.com/bioent/building/partnering/012003/full/nbt0598supp_31.html
  • Bioentrepreneur - starting a business

• http://www.nature.com/bioent/building/regional/012003/full/nbt0599supp_35.html
  • "Not enough biotechs, and what government can do about it"

• http://www.nature.com/bioent/building/tech/062003/full/bioent739.html
  • "U2B: A new model for technology transfer"

• http://www.palgrave-journals.com/jcb/journal/v13/n1/abs/3050032a.html
  • "Using intellectual property to map the organisational evolution of firms"

• http://www.palgrave-journals.com/jcb/journal/v10/n2/abs/3040070a.html
  • "The research tool patent revival"

• http://www.nature.com/bioent/2008/080401/full/bioe.2008.5.html
  • "Leveraging your biotech intellectual property"

• http://www.nature.com/bioent/2008/080401/full/bioe.2008.4.html
  • "Learning from each other"

• http://www.nature.com/bioent/building/tech/072005/full/bioent869.html
  • "Utopia, karma, and reality: three views on sharing resources among multiple institutions"

• http://www.nature.com/bioent/building/ip/012003/full/nbt1101-1075.html
  • "Research tool patents: tips for facing a "pay up now or litigate" ultimatum"

• http://www.nature.com/bioent/building/infra/012003/full/nbt0601supp_BE44.html
  • "The headache of knowledge management"

• http://www.nature.com/bioent/view/052003/full/bioent733.html

• http://www.nature.com/bioent/building/ip/012003/full/nbt0601supp_BE5.html

• http://www.nature.com/bioent/building/ip/042006/full/bioent907.html

• http://www.nature.com/nrd/journal/v5/n4/abs/nrd2019.html
  • Nature Reviews on Drug Discoveries

Books: (some you can read online)

Friedman, Yali. Building Biotechnology. http://www.amazon.com/Building-Biotechnology-Business-Regulations-Politics/dp/0973467665/ref=si3_rdr_bb_product

The Economic Dynamics of Modern Biotechnology. http://books.google.com/books?id=oxSNWloXXVAC&pg=PA54&dq=Open+Business+in+Biotechnology&lr=&ei=oBSvSdKIOKKIyATM5biQBQ#PPR6,M1

Ono, Dana, The Business of Biotechnoloty. http://search.barnesandnoble.com/booksearch/isbninquiry.asp?r=1&ean=0750691190

Biobazaar: The Open Source Revolution. http://books.google.com/books?id=IPTwYNqpJWgC&pg=PA53&dq=Open+Business+in+Biotechnology&ei=RAKvScnxCZvWzASgmoCJCQ#PPA72,M1

Biotechnology in Comparative Perspective. http://books.google.com/books?id=B4xBuHH-TmcC&pg=PA181&dq=Open+Business+in+Biotechnology&ei=RAKvScnxCZvWzASgmoCJCQ#PPA29,M1

Friedman, Yali. The Business of Biotech. http://books.google.com/books?id=-RWJa1KrkusC&pg=PA149&dq=Open+Business+in+Biotechnology&lr=&ei=oBSvSdKIOKKIyATM5biQBQ#PPA186,M1

Acharya, Rohini, The Emergence and Growth of Biotechnology: Experiences in Industrialized and Developing Countries. Cheltanham, UK: Edward Elgar, 1999.

Others

http://oba.od.nih.gov/oba/index.html

Blogs

http://patentbaristas.com/

Market Overview

• http://www.hoovers.com/biotechnology-sector/--ID__174--/free-ind-fr-profile-basic.xhtml
  • describes basic methods, costs, and goals of the biotech industry

• http://www.ibisworld.com/industry/retail.aspx?indid=2001&chid=1
  • identifies key products and services, as well as market size and distribution

• http://www.biotechinstitute.org/what_is/industry_facts.html
  • defines key sub-industries of biotech, as well as 'fun facts' about the industry: who regulates it, how much is spent on R&D, etc. No systematic presentation of information

• http://www.bio.org/speeches/pubs/er/statistics.asp
  • sales, revenue, number of companies, and R&D investment by year

• http://bio.org/ataglance/
  • defines industry, applications, processes and timeline

• http://knol.google.com/k/krishan-maggon/pharmaceutical-and-biotechnology/3fy5eowy8suq3/4#
  • hard to measure biotech productivity. No clear connection between R&D investment and payoff

• http://rsss.anu.edu.au/~janeth/BiotechInd.html
  • major research tools and products

• http://rsss.anu.edu.au/~janeth/IPIndust.html
  • problems of intellectual property regimes in Biotech, with specific reference to anticommons problems in the Agriculture Biotech industry

• http://biz.yahoo.com/ic/515.html
  • stock ticker for biotech companies

• http://money.cnn.com/data/sectors/Biotechnology/
  • stock ticker for biotech companies

• Penhoet, Ed. "The Biotechnology Industry from Birth to Adolescence", in Biotechnology: Essays from its Heartland, Lynn Yarris, ed. San Francisco: BASIC, 2004.

• Phillips, Theresa, "Biotech Business Models," About.com, September 19, 2007. Last Accessed March 13, 2009. Available at: http://biotech.about.com/b/2007/09/19/biotech-business-models.htm

• Pareras, Luis, "Biotech Business Models," Healthonomics, January 6, 2008/. Last Accessed March 13, 2009. Available at: http://www.healthonomics.org/2008/01/biotech-business-models.html

• McKelvey, Maureen, Annika Rickne and Jens Laage-Hellman, “Stylized facts about innovation processes in modern biotechnology,” in The Economic Dynamics of Modern Biotechnology. Cheltenham, UK: Edward Elgar, 2004.
  • Information about innovation processes

• Kalil, Thomas, University-Industry Partnerships in the Life Sciences: A University of California, Berkeley Perspective,

• Oliver, Richard, The Coming Biotech Age: The Business of Bio-Materials, New York: McGraw-Hill, 2000.

• Gaisford, James D., and Jill E. Hobbs, William A. Kerr, Nicholas Perdikis, Mari D. Plunkett, The Economics of Biotechnology. Cheltenham, UK. Edward Elgar, 2001.

• Beyond Borders: Global Biotechnology report, 2007. Ernst and Young. Available at: http://www.ey.com/global/content.nsf/International/Biotechnology_Library_Beyond_Borders_2007

• Council for Entrepreneurial Development, "2007 CED North Carolina Venture Report." 2007.

• Pisano, Gary P., "Can Science Be a Business? Lessons from Biotech" Harvard Business Review, Oct2006, Vol. 84 Issue 10, p114-125

• Guo, Re-Jing, Baruch Lev, and Nan Zhou, “Competitive Costs of Disclosure by Biotech IPOs” Journal of Accounting Research, Vo. 42 No. 2 May 2004

• Alonso-Zaldivar, Ricardo, “FDA pledges openness on gene-altered products,” wtop.com, January 15, 2009. Last Accessed March 14, 2009. http://www.wtopnews.com/?nid=106&sid=1575167

• Pisano, Gary P. Science Business: The Promise, the Reality, and the Future of Biotech, Boston: Harvard Business School Press, 2006.

• Oliver, Amalya L., "University-Based Biotechnology Spin-Offs," in Handbook of Bioentrepreneurship, Holger Patzelt and Thomas Brenner, eds. New York: Springer, 2008